Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Nonsteroidal anti-inflammatory agents and musculoskeletal injuries in Thoroughbred racehorses in Kentucky.

Dirikolu L, Woods WE, Boyles J, Lehner AF, Harkins JD, Fisher M, Schaeffer DJ, Tobin T.

J Vet Pharmacol Ther. 2009 Jun;32(3):271-9. doi: 10.1111/j.1365-2885.2008.01038.x.

PMID:
19646092
2.

Pyrilamine in the horse: detection and pharmacokinetics of pyrilamine and its major urinary metabolite O-desmethylpyrilamine.

Dirikolu L, Lehner AF, Harkins JD, Woods WE, Karpiesiuk W, Gates RS, Fisher M, Tobin T.

J Vet Pharmacol Ther. 2009 Feb;32(1):66-78. doi: 10.1111/j.1365-2885.2008.01005.x.

PMID:
19161458
3.

New therapeutic approaches for equine protozoal myeloencephalitis: pharmacokinetics of diclazuril sodium salts in horses.

Dirikolu L, Karpiesiuk W, Lehner AF, Hughes C, Woods WE, Harkins JD, Boyles J, Atkinson A, Granstrom DE, Tobin T.

Vet Ther. 2006 Spring;7(1):52-63, 72.

PMID:
16598684
4.

Development of a method for the detection and confirmation of the alpha-2 agonist amitraz and its major metabolite in horse urine.

Lehner AF, Hughes CG, Karpiesiuk W, Harkins JD, Dirikolu L, Bosken J, Camargo F, Boyles J, Troppmann A, Woods WE, Tobin T.

J Anal Toxicol. 2004 Oct;28(7):553-62.

PMID:
15516314
5.

Detection and confirmation of ractopamine and its metabolites in horse urine after Paylean administration.

Lehner AF, Hughes CG, Harkins JD, Nickerson C, Mollett B, Dirikolu L, Bosken J, Camargo F, Boyles J, Troppmann A, Karpiesiuk WW, Woods WE, Tobin T.

J Anal Toxicol. 2004 May-Jun;28(4):226-38.

PMID:
15189672
6.

Detection, quantification, metabolism, and behavioral effects of selegiline in horses.

Dirikolu L, Lehner AF, Karpiesiuk W, Hughes C, Woods WE, Boyles J, Harkins JD, Troppmann A, Tobin T.

Vet Ther. 2003 Fall;4(3):257-68.

PMID:
15136987
7.

Detection, quantification, and pharmacokinetics of furosemide and its effects on urinary specific gravity following IV administration to horses.

Dirikolu L, Lehner AF, Hughes C, Karpiesiuk W, Camargo FC, Harkins JD, Woods WE, Bosken JM, Boyles J, Troppmann A, Fisher M, Tobin T.

Vet Ther. 2003 Winter;4(4):350-63.

PMID:
15136977
8.

A GC-MS method for the determination of isoxsuprine in biological fluids of the horse utilizing electron impact ionization.

Bosken JM, Lehner AF, Hughes CG, Woods WE, Camargo FC, Harkins JD, Boyles J, Tobin T.

J Anal Toxicol. 2004 Jan-Feb;28(1):27-34.

PMID:
14987421
9.

Apparent ELISA detection times for albuterol after administration with the torpex equine inhaler device.

Dirikolu L, Mollett BA, Troppmann A, Woods WE, Bratton C, Cashman CP, Schroedter D, Mayer B, Lehner AF, Karpiesiuk W, Hughes C, Boyles J, Harkins JD, Tobin T.

Vet Ther. 2002 Fall;3(3):297-307. Erratum in: Vet Ther. 2002 Winter;3(4):363..

PMID:
12447838
10.

Ropivacaine in the horse: its pharmacological responses, urinary detection and mass spectral confirmation.

Harkins JD, Karpiesiuk W, Lehner A, Woods WE, Dirikolu L, Carter WG, Boyles J, Tobin T.

J Vet Pharmacol Ther. 2001 Apr;24(2):89-98.

PMID:
11442782
11.

Clenbuterol in the horse: confirmation and quantitation of serum clenbuterol by LC-MS-MS after oral and intratracheal administration.

Lehner AF, Harkins JD, Karpiesiuk W, Woods WE, Robinson NE, Dirikolu L, Fisher M, Tobin T.

J Anal Toxicol. 2001 May-Jun;25(4):280-7.

PMID:
11386642
12.

Comparison of the quantification of caffeine in human plasma by gas chromatography and ELISA.

Carregaro AB, Woods WE, Tobin T, Queiroz-Neto A.

Braz J Med Biol Res. 2001 Jun;34(6):821-4.

13.

Clenbuterol in the horse: urinary concentrations determined by ELISA and GC/MS after clinical doses.

Harkins JD, Woods WE, Lehner AF, Fisher M, Tobin T.

J Vet Pharmacol Ther. 2001 Feb;24(1):7-14.

PMID:
11348482
14.

Intratracheal clenbuterol in the horse: its pharmacological efficacy and analytical detection.

Harkins JD, Robinson NE, Woods WE, Lehner AF, Smith MD, Gates RS, Fisher M, Tobin T.

J Vet Pharmacol Ther. 2000 Aug;23(4):251-60.

PMID:
11106998
15.

Identification of lidocaine and its metabolites in post-administration equine urine by ELISA and MS/MS.

Dirikolu L, Lehner AF, Karpiesiuk W, Harkins JD, Woods WE, Carter WG, Boyles J, Fisher M, Tobin T.

J Vet Pharmacol Ther. 2000 Aug;23(4):215-22.

PMID:
11106996
16.

Remifentanil in the horse: identification and detection of its major urinary metabolite.

Lehner AF, Almeida P, Jacobs J, Harkins JD, Karpiesiuk W, Woods WE, Dirikolu L, Bosken JM, Carter WG, Boyles J, Holtz C, Heller T, Nattrass C, Fisher M, Tobin T.

J Anal Toxicol. 2000 Jul-Aug;24(5):309-15.

PMID:
10926352
17.

Direct MS-MS identification of isoxsuprine-glucuronide in post-administration equine urine.

Bosken JM, Lehner AF, Hunsucker A, Harkins JD, Woods WE, Karpiesiuk W, Carter WG, Boyles J, Fisher M, Tobin T.

Can J Vet Res. 2000 Apr;64(2):112-6.

18.

Diclazuril in the horse: its identification and detection and preliminary pharmacokinetics.

Dirikolu L, Lehner F, Nattrass C, Bentz BG, Woods WE, Carter WG, Karpiesiuk W, Jacobs J, Boyles J, Harkins JD, Granstrom DE, Tobin T.

J Vet Pharmacol Ther. 1999 Dec;22(6):374-9.

PMID:
10651466
19.

Bupivacaine in the horse: relationship of local anaesthetic responses and urinary concentrations of 3-hydroxybupivacaine.

Harkins JD, Lehner A, Karpiesiuk W, Woods WE, Dirikolu L, Boyles J, Carter WG, Tobin T.

J Vet Pharmacol Ther. 1999 Jun;22(3):181-95.

PMID:
10447829
20.

Mepivacaine: its pharmacological effects and their relationship to analytical findings in the horse.

Harkins JD, Karpiesiuk W, Woods WE, Lehner A, Mundy GD, Rees WA, Dirikolu L, Bass S, Carter WG, Boyles J, Tobin T.

J Vet Pharmacol Ther. 1999 Apr;22(2):107-21.

PMID:
10372595

Supplemental Content

Loading ...
Support Center